Efficacy and Safety of Sequential Surgical Resection After Pembrolizumab Plus Chemotherapy for Initial Unresectable Stage IIIB NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Efficacy and surgical safety of sequential surgical resection after pembrolizumab plus chemotherapy for initial unresectable stage IIIB non-small cell lung cancer
Lung Cancer 2023 Oct 01;184(xx)107326, J Zheng, Y Li, C Jin, K Ruan, K Sun, H Chen, M Wang, S Zhang, J Zhou, J ZhouFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.